Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly targeting tyrosine kinases involved in inflammatory and oncogenic signaling pathways. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in developing treatments for autoimmune diseases and certain cancers. Also employed in the design of covalent inhibitors due to the acryloyl group, which enables irreversible binding to cysteine residues in target proteins. Additionally, it serves as a building block in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.